AltRx Reviews (2026): Is the $89 GLP-1 Legit?

The $89 question: what the entry price actually is

AltRx’s advertised $89-a-month price for compounded semaglutide is a limited-time promotional rate, not what most patients end up paying month to month. An independent review of AltRx reports the standard, non-promotional semaglutide rate at $199 a month once the introductory period ends, more than double the headline figure. Source: exploretreatments.com.

Tirzepatide tells the same story with a different number. AltRx’s own live product page prices compounded tirzepatide at $149 a month, with no “starting at” qualifier attached, meaning that appears to be the standing price on AltRx’s own site, not a promotion (altrx.com). A separate independent review reports a different structure again: a $129-a-month promotional rate against a $299-a-month standard rate (exploretreatments.com). None of the sources checked corroborate a flat $99-a-month tirzepatide price.

Prices verified 16 July 2026; confirm your current price with AltRx before you pay, since a promotional rate can expire between when you read this and when you reach the payment step. Given the gap between the $89 headline and the $199 to $299 figures corroborated above, budgeting around the advertised price rather than the standard price is the single most common way to be surprised by an AltRx bill.

The BBB record

The Better Business Bureau rates altRx, Inc F, citing “failure to respond to 37 complaint(s) filed against business,” and altRx, Inc is not BBB accredited, according to BBB’s own profile for the company, read directly on 16 July 2026 (bbb.org). The legal business name on file is altRx, Inc, based in Miami, Florida.

An F is BBB’s lowest letter grade, and the specific reason BBB gives here is not a dispute over any individual complaint’s merits, it is that the business did not respond to 37 complaints filed against it. That is a distinct, sourced fact worth stating plainly: according to BBB’s own record, altRx, Inc did not respond to 37 complaints filed against the business, whatever the underlying disputes were about. This page does not know the content of those 37 complaints beyond what BBB’s summary states, and does not attribute anything to AltRx beyond what the source says.

What AltRx says it offers

AltRx displays a “LegitScript Certified” badge twice in its own site footer, each linking to a LegitScript verification page, but an independent lookup of that page could not confirm current certification status. The badge and the link are real and visible on altrx.com as of 16 July 2026; what could not be confirmed is whether LegitScript’s own database currently lists AltRx as certified. Report it precisely: the claim is present and repeated on AltRx’s own site, and it is unconfirmed independently, not confirmed and not shown to be false.

AltRx also has an active Trustpilot profile at trustpilot.com/review/altrx.com, which is worth reading in full before you decide. This page will not state a Trustpilot score or star distribution for AltRx: a number that moves week to week is not something this page can responsibly print as a fixed fact, so read the live profile yourself and weigh it against the BBB record above.

Who AltRx is not for

AltRx is not the right choice for anyone budgeting around the $89 headline as their real ongoing cost, because it is not the standing price. Once the promotional period ends, an independent review puts the standard semaglutide rate at $199 a month, more than double the advertised figure, and the tirzepatide numbers are similarly higher than the $99 previously claimed. Anyone who cannot absorb that increase after the first month or two should compare AltRx’s real cost against TrimRx’s flat $199-a-month semaglutide and $349-a-month tirzepatide rates before assuming AltRx is cheaper.

It is also not the right choice for anyone for whom a responsive complaint history matters. BBB currently rates altRx, Inc F for failing to respond to 37 complaints, a specific, sourced, actionable data point that a prospective patient can weigh directly rather than take on faith.

Finally, anyone who needs LegitScript certification confirmed as a hard requirement, rather than taken on the strength of a badge on AltRx’s own site, should verify it independently before paying. The badge is real and visible on altrx.com, but an independent LegitScript lookup could not confirm current status, so this page cannot settle the question for you.

How AltRx compares

AltRx scores 0.5 out of 5 on this site’s rubric, the second-lowest of the five providers evaluated, held down by the BBB F rating, the contradicted pricing, and the absence of independent price transparency. The table below applies the same five criteria and 0-to-2 scoring shown in AltRx’s own rubric above to all five providers, using the same evidence table, so the comparison is apples to apples.

AltRx’s only point on this table is certification, and even that is unconfirmed independently, just a badge on its own site that this page could not verify through LegitScript directly. Every other criterion scores zero: no BBB accreditation, and an F rating on top of that, no corroborated dose-flat pricing, no independently transparent pricing (the sources checked contradict AltRx’s own advertised numbers rather than confirm them), and no track record credited, given the BBB complaint pattern above.

What you can be prescribed

AltRx prescribes compounded semaglutide and compounded tirzepatide, the same two GLP-1-class medications every provider scored on this site prescribes. The decision in front of you is not which medication you can access, it is whether AltRx’s real price, once the promotion ends, and its BBB record are ones you are comfortable with.

If the BBB record or the gap between the advertised and standard prices above is a dealbreaker for you, that is a reasonable conclusion from real, sourced evidence, and the comparison table gives you a same-criteria look at TrimRx, Joi & Blokes, ReadyRx and Zevay rather than just a different logo.